Annual Total Liabilities
$53.28 M
-$11.54 M-17.81%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual total liabilities is $53.28 million, with the most recent change of -$11.54 million (-17.81%) on December 31, 2023.
- During the last 3 years, EIGR annual total liabilities has risen by +$4.72 million (+9.73%).
- EIGR annual total liabilities is now -25.60% below its all-time high of $71.61 million, reached on December 1, 2011.
Performance
EIGR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$53.28 M
-$3.97 M-6.94%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly total liabilities is $53.28 million, with the most recent change of -$3.97 million (-6.94%) on December 31, 2023.
- Over the past year, EIGR quarterly total liabilities has dropped by -$11.54 million (-17.81%).
- EIGR quarterly total liabilities is now -18.57% below its all-time high of $65.44 million, reached on September 30, 2022.
Performance
EIGR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EIGR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.8% | -17.8% |
| 3 y3 years | +9.7% | +9.7% |
| 5 y5 years | +48.6% | +48.6% |
EIGR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | at low | -18.6% | at low |
| 5 y | 5-year | -17.8% | +9.7% | -18.6% | +19.3% |
| alltime | all time | -25.6% | +2183.9% | -18.6% | +2818.1% |
Eiger BioPharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $53.28 M(-17.8%) | $53.28 M(-6.9%) |
| Sep 2023 | - | $57.26 M(+0.3%) |
| Jun 2023 | - | $57.06 M(-10.8%) |
| Mar 2023 | - | $63.99 M(-1.3%) |
| Dec 2022 | $64.83 M(+20.0%) | $64.83 M(-0.9%) |
| Sep 2022 | - | $65.44 M(+7.7%) |
| Jun 2022 | - | $60.77 M(+8.4%) |
| Mar 2022 | - | $56.06 M(+3.8%) |
| Dec 2021 | $54.00 M(+11.2%) | $54.00 M(+6.3%) |
| Sep 2021 | - | $50.81 M(+6.5%) |
| Jun 2021 | - | $47.71 M(-3.3%) |
| Mar 2021 | - | $49.33 M(+1.6%) |
| Dec 2020 | $48.56 M(-0.2%) | $48.56 M(+1.7%) |
| Sep 2020 | - | $47.74 M(+6.9%) |
| Jun 2020 | - | $44.67 M(-1.2%) |
| Mar 2020 | - | $45.20 M(-7.1%) |
| Dec 2019 | $48.66 M(+35.7%) | $48.66 M(+0.7%) |
| Sep 2019 | - | $48.34 M(+7.8%) |
| Jun 2019 | - | $44.85 M(+6.0%) |
| Mar 2019 | - | $42.30 M(+18.0%) |
| Dec 2018 | $35.86 M | $35.86 M(+6.7%) |
| Sep 2018 | - | $33.61 M(+29.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $26.06 M(+33.7%) |
| Mar 2018 | - | $19.49 M(-4.3%) |
| Dec 2017 | $20.36 M(+1.7%) | $20.36 M(-1.8%) |
| Sep 2017 | - | $20.73 M(-0.3%) |
| Jun 2017 | - | $20.79 M(+10.0%) |
| Mar 2017 | - | $18.90 M(-5.6%) |
| Dec 2016 | $20.02 M(+757.9%) | $20.02 M(+273.3%) |
| Sep 2016 | - | $5.36 M(+91.2%) |
| Jun 2016 | - | $2.80 M(-65.5%) |
| Mar 2016 | - | $8.13 M(+248.3%) |
| Dec 2015 | $2.33 M(-86.3%) | $2.33 M(+27.8%) |
| Sep 2015 | - | $1.83 M(-89.3%) |
| Jun 2015 | - | $17.13 M(+13.2%) |
| Mar 2015 | - | $15.13 M(-11.0%) |
| Dec 2014 | $17.01 M(+41.2%) | $17.01 M(+13.9%) |
| Sep 2014 | - | $14.93 M(+302.1%) |
| Jun 2014 | - | $3.71 M(-7.1%) |
| Mar 2014 | - | $4.00 M(-66.8%) |
| Dec 2013 | $12.05 M(-0.2%) | $12.05 M(+265.0%) |
| Sep 2013 | - | $3.30 M(-58.3%) |
| Jun 2013 | - | $7.91 M |
| Dec 2012 | $12.07 M(-83.1%) | - |
| Dec 2011 | $71.61 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual total liabilities year-on-year change?
- What is Eiger BioPharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly total liabilities year-on-year change?
What is Eiger BioPharmaceuticals annual total liabilities?
The current annual total liabilities of EIGR is $53.28 M
What is the all time high annual total liabilities for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual total liabilities is $71.61 M
What is Eiger BioPharmaceuticals annual total liabilities year-on-year change?
Over the past year, EIGR annual total liabilities has changed by -$11.54 M (-17.81%)
What is Eiger BioPharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of EIGR is $53.28 M
What is the all time high quarterly total liabilities for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly total liabilities is $65.44 M
What is Eiger BioPharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, EIGR quarterly total liabilities has changed by -$11.54 M (-17.81%)